A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease

Patients at high risk of rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) would benefit from being identified before the onset of respiratory symptoms; this can be done by screening patients with the use of chest high‐resolution computed tomography (HRCT). Our objective was to develop and validate a risk score for patients who have subclinical RA‐ILD.

[1]  P. Emery,et al.  Current issues in rheumatoid arthritis-associated interstitial lung disease , 2021, The Lancet Rheumatology.

[2]  M. Pirinen,et al.  Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers , 2021, Annals of the Rheumatic Diseases.

[3]  J. Sparks.  Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease , 2021, Annals of the Rheumatic Diseases.

[4]  P. Spagnolo,et al.  Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. , 2021, The Lancet. Respiratory medicine.

[5]  M. Dougados,et al.  Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort. , 2021, Rheumatology.

[6]  M. Weinblatt,et al.  Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease , 2020, The Journal of Rheumatology.

[7]  R. Porcher,et al.  Methotrexate and rheumatoid arthritis associated interstitial lung disease , 2020, European Respiratory Journal.

[8]  N. Seersholm,et al.  Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. , 2020, Rheumatology.

[9]  O. Hilberg,et al.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality , 2019, Respiration.

[10]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[11]  E. Karlson,et al.  Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study , 2019, Arthritis & rheumatology.

[12]  T. Doyle,et al.  Development of a Risk Indicator Score for the Identification of Interstitial Lung Disease in Patients With Rheumatoid Arthritis. , 2019, Reumatologia clinica.

[13]  A. Giovagnoni,et al.  THU0154 HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) OF THE LUNG IN PATIENTS WITH RHEUMATOID ARTHRITIS: PREVALENCE OF INTERSTITIAL LUNG DISEASE INVOLVEMENT AND DETERMINANTS OF ABNORMALITIES , 2019, Poster Presentations.

[14]  D. Walsh,et al.  Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts , 2019, BMJ Open.

[15]  Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality , 2019, The Journal of Rheumatology.

[16]  N. Mena-Vázquez,et al.  Analysis of Clinical-Analytical Characteristics in Patients with Rheumatoid Arthritis and Interstitial Lung Disease: Case-Control Study. , 2019, Reumatologia clinica.

[17]  M. Nalls,et al.  MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease , 2018, The New England journal of medicine.

[18]  Takeshi Johkoh,et al.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[19]  O. Hilberg,et al.  A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality , 2017, Annals of the rheumatic diseases.

[20]  J. Nolla,et al.  Preclinical lung disease in early rheumatoid arthritis , 2016, Chronic respiratory disease.

[21]  G. Washko,et al.  Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. , 2015, American journal of respiratory and critical care medicine.

[22]  D. Lynch,et al.  CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society. , 2015, The Lancet. Respiratory medicine.

[23]  Gary S Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[24]  A. Young,et al.  Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. , 2014, Rheumatology.

[25]  L. Klareskog,et al.  Structural Changes and Antibody Enrichment in the Lungs Are Early Features of Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis , 2014, Arthritis & rheumatology.

[26]  Yonghong Shi,et al.  Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease , 2013, Clinical & developmental immunology.

[27]  Raúl San José Estépar,et al.  MUC5B promoter polymorphism and interstitial lung abnormalities. , 2013, The New England journal of medicine.

[28]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[29]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[30]  Nigel Cox,et al.  Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. , 2010, Rheumatology.

[31]  Cynthia S Crowson,et al.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. , 2010, Arthritis and rheumatism.

[32]  J. Kanne.  Interstitial lung disease (ILD): imaging finding, and the role of imaging in evaluating the patient with known or suspected ILD. , 2010, Seminars in roentgenology.

[33]  W. Travis,et al.  Progressive preclinical interstitial lung disease in rheumatoid arthritis. , 2008, Archives of internal medicine.

[34]  M. Dougados,et al.  The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. , 2007, Joint, bone, spine : revue du rhumatisme.

[35]  E. Gabbay,et al.  Interstitial lung disease in recent onset rheumatoid arthritis. , 1997, American journal of respiratory and critical care medicine.

[36]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.